---

title: 'Neutropenic Fever and Cancer'
authors:
    - 'Michelle Lin, MD'
created: 2011/10/07
updates:
    - 2011/10/07
categories:
    - 'Hematology and Oncology'
drugs: 'ciprofloxacin, vancomycin, cefipime, pipercillin-tazobactam, amoxicillin-clavulanate, aztreonam'

---


# Neutropenic Fever and Cancer

Chemotherapy causes neutropenia in 10-50% of patients with solid tumors and &gt; 80% of patients with hematologic malignancies during chemotherapy cycle

**Fever:** ≥ 38.3 C (101 F) or ≥ 38.0 C (100.4 F) over 1-hour period

**Neutropenia:** Absolute neutrophil count &lt; 500 cells/mm3

## MASCC score

**Multinational Association for Supportive Care in Cancer (MASCC) Score:**

|                                                                                                                   |                  |
|-------------------------------------------------------------------------------------------------------------------|------------------|
| **Burden of febrile neutropenia** | 5 pts (mild), 3 pts (moderate)  |
| **No hypotension (SBP ≥ 90 mmHg)**                                                                                |  5 pts           |
| **No COPD**                                                                                                       |  4 pts           |
| **Solid tumor or hematologic malignancy <span class="drug">with</span> no previous fungal infection**                                                                                |  4 pts           |
| **No dehydration requiring parenteral fluids**                                                                    |  3 pts           |
| **Outpatient status**                                                                                             |  3 pts           |
| **Age &lt; 60 years**                                                                                             |  2 pts           |

**HIGH RISK PATIENTS** (require admission):
-   MASCC score &lt; 21 **OR**
-   Any of clinical findings:
    -   Prolonged (&gt; 7 days duration) and profound neutropenia (ANC ≤ 100 cells/mm3)
    -   Hypotension
    -   Pneumonia
    -   New abdominal pain
    -   Neurologic changes

**LOW RISK PATIENTS** (may be eligible for outpatient tx):
-   MASCC score ≥ 21
-   Brief (≤ 7 days duration) neutropenic periods and few co-morbidities

## Workup

-   CBC, BUN/Creatinine, electrolytes, AST/ALT, bilirubin
-   Chest xray, if respiratory signs or symptoms
-   2 Blood Cx (1 central line lumen if present + 1 peripheral vein, or 2 peripheral veins)

## Antibiotic Treatment

*Monotherapy:* Antipseudomonal beta-lactam (eg. **<span class="drug">cefipime</span>, <span class="drug">carbapenem</span>, <span class="drug">pip-tazo</span>**)
**<span class="drug">Vancomycin</span>**is not always indicated in cancer patients with a neutropenic fever.
-   Add **vancomycin** only if suspect catheter-related infection, skin/soft tissue infection, pneumonia, hemodynamic instability, colonization with MRSA/VRE/PCN-resistant *Strep pneumoniae*

*For PCN allergy*: **<span class="drug">Ciprofloxacin</span> + <span class="drug">clindamycin</span>,** or **<span class="drug">aztremonam</span> + <span class="drug">vancomycin</span>**
*For PO outpatient*: **<span class="drug">Ciprofloxacin</span> + <span class="drug">amoxicillin-clavulanate</span> **

## Central line-associated blood stream infection (CLABSI)

**Remove catheter:** Consider removal if any of following: 

-   Caused by *S. aureus*, *P. aeruginosa*, fungi, mycobacteria
-   Tunnel infection
-   Pocket site infection
-   Septic thrombosis
-   Endocarditis
-   Sepsis with hemodynamic instability
-   Bacteremia despite ≥ 72 hours antibiotics

**Keep catheter** and treat with abx: If coag-negative staph

## Example

A 65 y/o man with a history of prostate cancer presents to your ED from home appearing fairly well and a mild cough for 3 days. He has otherwise no past medical problems. His vital signs are:

-   Temperature 39 C
-   BP 160/80
-   HR 60
-   RR 14
-   Oxygen saturation 99% on room air

His absolute neutrophil count (ANC) comes back at 300 cells/mm3. His chest xray shows a right middle lobe pneumonia and a central line catheter tip ending in the SVC.

**Questions:**

-   Is this a patient "high" or "low" risk per the Multinational Association for Supportive Care in Cancer (MASCC)? (<span class="aglmd-moreinfo ui-moreinfo" data-iid="53aa2472d35d3ae92e001575">View answer</span>)
-   Does this person require inpatient admission? (<span class="aglmd-moreinfo ui-moreinfo" data-iid="53aa2472d35d3ae92e001576">View answer</span>)
-   What antibiotics would you start on this patient? (<span class="aglmd-moreinfo ui-moreinfo" data-iid="53aa2472d35d3ae92e001577">View answer</span>)

## References

-   [Fairefield AG et. al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer. 2010 update by the IDSA. Clinical Infectious Disease 2011; 52 (4): e56-93.](http://www.ncbi.nlm.nih.gov/pubmed/21205990)
